The funding will support Inito’s global expansion of its hormone test, building even more advanced analytics using AI and invest in R&D for new tests. In the long term, Inito envisions offering diagnostic tests for various health concerns through a smartphone-based platform, empowering users with insights about their health, the company said in a statement on Thursday.
The startup’s flagship product – Fertility Monitor is a home test that helps women track fertility hormones in 10 mins and provides advanced personalised analytics about women’s reproductive health. The technology used by Inito uses a combination of hardware, biotechnology and machine learning.
“The partnership with Fireside Ventures has not only provided crucial financial backing but also valuable mentorship and strategic guidance, enabling Inito to build a leading consumer health tech brand for the world from India,” said the firm’s co-founders Aayush Rai and Varun AV.